In a study comparing the two drugs for weight loss, people lost an average of 5.9% of their body weight in three months with Tirzepatide, compared to 3.6% with Semaglutide [1]
Most common adverse reactions for Wegovy (semaglutide) The most common adverse reactions for Wegovy (incidence 5%) are nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss
Court leadership needs to get to work on setting schedules and making requests for documents from the drug manufacturers Novo Nordisk and Lilly, formerly known as Eli Lilly
According to the company, many patients may be prescribed after the assessment, though some may need a telehealth consultation